Infusystem Holdings, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
AMEX
InfuSystem Holdings, Inc. reported a significant increase in net revenues and net income for the fiscal year ended December 31, 2025, driven by strong performance in its Patient Services segment and improved gross margins.
AMEX
InfuSystem Holdings, Inc. reports a 7.2% increase in net revenues and improved profitability for the fiscal year ended December 31, 2024, driven by growth in both Patient Services and Device Solutions segments.
AMEX
InfuSystem Holdings, Inc. reports a 14.4% increase in net revenue for fiscal year 2023, driven by growth in both Patient Services and Device Solutions segments.